Literature DB >> 23558130

[A case of pancreatic neuroendocrine tumor with excessively-advanced liver metastasis treated with S-1/GEM combination chemotherapy plus the long-acting somatostatin analogue octreotide].

Yukinari Yoshida1, Nobuaki Sugawara, Takae Minami, Norikazu Iwata, Kimiko Ikeda, Takao Endoh, Hironobu Sasano.   

Abstract

A 41-year-old woman who had a pancreatic tail tumor and multiple liver tumors was referred to our hospital. The results of abdominal US, CT and MRI, and histopathological and immunohistochemical findings of the liver tumor biopsy revealed a pancreatic neuroendocrine tumor with excessively-advanced liver metastasis. We treated her with S-1/gemcitabine combination chemotherapy plus long-acting somatostatin analogue octreotide, which produced tumor stabilization and good quality of life for 7 months, and survival time of 15 months. Although the tumor was diagnosed as a poorly differentiated endocrine carcinoma, this therapy was suggested to be effective in this case.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558130

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  2 in total

1.  A case report of mixed acinar-endocrine carcinoma of the pancreas treated with S-1 chemotherapy: Does it work or induce endocrine differentiation?

Authors:  Masataka Yokode; Ryosuke Itai; Yukimasa Yamashita; Yoh Zen
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

2.  Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma).

Authors:  Sakura Hiraide; Sadahide Ono; Satoshi Kato
Journal:  Case Rep Oncol       Date:  2017-05-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.